Noureddin, M., Jones, C., Gomez, E. V., Alkhouri, N., Therapondos, G., Mantry, P., … Rinella, M. (2020). Screening for non-alcoholic fatty liver disease in persons with type 2 diabetes in the US is cost effective: A comprehensive economical analysis. In JOURNAL OF HEPATOLOGY (Vol. 73, pp. S136–S137).

Noureddin, Mazen, Calum Jones, Eduardo Vilar Gomez, Naim Alkhouri, George Therapondos, Parvez Mantry, Nigel Girgrah, et al. “Screening for non-alcoholic fatty liver disease in persons with type 2 diabetes in the US is cost effective: A comprehensive economical analysis.” In JOURNAL OF HEPATOLOGY, 73:S136–37, 2020.

Noureddin M, Jones C, Gomez EV, Alkhouri N, Therapondos G, Mantry P, et al. Screening for non-alcoholic fatty liver disease in persons with type 2 diabetes in the US is cost effective: A comprehensive economical analysis. In: JOURNAL OF HEPATOLOGY. 2020. p. S136–7.

Noureddin, Mazen, et al. “Screening for non-alcoholic fatty liver disease in persons with type 2 diabetes in the US is cost effective: A comprehensive economical analysis.” JOURNAL OF HEPATOLOGY, vol. 73, 2020, pp. S136–37.

Noureddin M, Jones C, Gomez EV, Alkhouri N, Therapondos G, Mantry P, Girgrah N, Mitchell E, Shea K, Sussman NL, Fuchs M, Diaz VF, Dinani A, Dieterich D, Rinella M. Screening for non-alcoholic fatty liver disease in persons with type 2 diabetes in the US is cost effective: A comprehensive economical analysis. JOURNAL OF HEPATOLOGY. 2020. p. S136–S137.